Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dishman Pharmaceuticals & Chemicals' unit Carbogen Amcis has acquired French contract development and manufacturing company, Creapharm Parenterals.
Subscribe to our email newsletter
Carbogen Amcis’ portfolio of development and manufacturing services will undergo an expansion with the addition of formulation, lyophilization services and sterile GMP capabilities.
The services are believed to bolster drug products’ development for preclinical studies and clinical trials.
Following the deal, Creapharm Parenterals will now be called Carbogen Amcis SAS.
The financial details of the transaction have not been revealed.